Skip to main content
Top
Published in: International Urology and Nephrology 4/2007

01-12-2007 | Original Article

Pediatric nephrology patients are overweight: 20 years' experience in a single Canadian tertiary pediatric nephrology clinic

Authors: Guido Filler, Sílvia Mansur Reimão, Anusha Kathiravelu, Joanne Grimmer, Janusz Feber, Alfred Drukker

Published in: International Urology and Nephrology | Issue 4/2007

Login to get access

Abstract

Background

Obesity is an independent risk factor for chronic kidney disease (CKD). We compared the body composition of pediatric nephrology patients with that of the general child population over 2 decades.

Methods

About 4,959 patients above 2 years of age (mean: 9.6 ± 4.5) were referred to a tertiary pediatric nephrology clinic from 1985 to 2006. In 3,422 patients (69.0% with the same mean age) there were sufficient data to analyze body composition, expressed as body mass index (BMI) Z-score and calculated on the basis of normal data taken from the National (USA) Center for Health Statistics (2000).

Results

Hematuria (21.68%), recurrent urinary tract infections (16.09%), proteinuria (13.95%) and hypertension (8.27%) were the most common referral diagnoses. Mean BMI Z-score of the pediatric nephrology patients increased significantly from 0.29 ± 1.07 during the years 1985–1991 to 0.44 ± 1.27 in 1992–1999 and 0.87 ± 1.70 in 2000–2006 (P < 0.0001, ANOVA). Whereas the rate of the increase in BMI Z-score was not statistically different from that seen in the normal population, the young nephrology patients had over the entire time consistently significantly higher BMI Z-scores (average +0.72) than the comparable normal USA data. Several disease groups with potential for development of CKD had higher BMI Z-scores than found in the age- and sex-adjusted control data.

Conclusions

The increased rate of obesity in our studied population suggests that pediatric nephrology patients are at even greater risk for developing CKD later in life than could be predicted from their renal disease only. We recommend therapeutic intervention to address this potentially modifiable risk factor.
Literature
1.
go back to reference Filler G, Payne RP, Orrbine E et al (2005) Changing trends in the referral patterns of pediatric nephrology patients. Pediatr Nephrol 20:603–608PubMedCrossRef Filler G, Payne RP, Orrbine E et al (2005) Changing trends in the referral patterns of pediatric nephrology patients. Pediatr Nephrol 20:603–608PubMedCrossRef
2.
go back to reference Rodriguez-Soriano J, Aguirre M, Oliveros R et al (2005) Long-term renal follow-up of extremely low birth weight infants. Pediatr Nephrol 20:579–584PubMedCrossRef Rodriguez-Soriano J, Aguirre M, Oliveros R et al (2005) Long-term renal follow-up of extremely low birth weight infants. Pediatr Nephrol 20:579–584PubMedCrossRef
3.
go back to reference Hsu CY, McCulloch CE, Iribarren C et al (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21–28PubMed Hsu CY, McCulloch CE, Iribarren C et al (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21–28PubMed
4.
go back to reference Ribstein J, du Cailar G, Mimran A (1995) Combined renal effects of overweight and hypertension. Hypertension 26:610–615PubMed Ribstein J, du Cailar G, Mimran A (1995) Combined renal effects of overweight and hypertension. Hypertension 26:610–615PubMed
5.
go back to reference Leiter LA, Abbott D, Campbell NR et al (1999) Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ 160(9 Suppl):S7–12 PubMed Leiter LA, Abbott D, Campbell NR et al (1999) Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ 160(9 Suppl):S7–12 PubMed
6.
go back to reference Celi F, Bini V, De Giorgi G et al (2003) Epidemiology of overweight and obesity among school children and adolescents in three provinces of central Italy, 1993–2001: study of potential influencing variables. Eur J Clin Nutr 57:1045–1051PubMedCrossRef Celi F, Bini V, De Giorgi G et al (2003) Epidemiology of overweight and obesity among school children and adolescents in three provinces of central Italy, 1993–2001: study of potential influencing variables. Eur J Clin Nutr 57:1045–1051PubMedCrossRef
7.
go back to reference Cameron N, Norgan NG, Ellison GTH (eds) (2006) Childhood obesity; contemparary issues, Soc for the study of human biology series. CRC Press, Boca Raton Fla., p 272 Cameron N, Norgan NG, Ellison GTH (eds) (2006) Childhood obesity; contemparary issues, Soc for the study of human biology series. CRC Press, Boca Raton Fla., p 272
8.
go back to reference Ogden CL, Fryar CD, Carroll MD, Flegal KM (2004) Mean bodyweight, height and body mass index. United States 1960–2002. Advance data from vital and health statistics; no 347. National Center for Health Statistics, Hyattsville, Maryland Ogden CL, Fryar CD, Carroll MD, Flegal KM (2004) Mean bodyweight, height and body mass index. United States 1960–2002. Advance data from vital and health statistics; no 347. National Center for Health Statistics, Hyattsville, Maryland
9.
go back to reference Cook S, Weitzman M, Auinger P et al (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157:821–827PubMedCrossRef Cook S, Weitzman M, Auinger P et al (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157:821–827PubMedCrossRef
10.
go back to reference Strauss RS, Pollack HA (2001) Epidemic increase in childhood overweight, 1986–1998. JAMA 286:2845–2848PubMedCrossRef Strauss RS, Pollack HA (2001) Epidemic increase in childhood overweight, 1986–1998. JAMA 286:2845–2848PubMedCrossRef
12.
go back to reference Willms JD, Tremblay MS, Katzmarzyk PT (2003) Geographic and demographic variation in the prevalence of overweight Canadian children. Obes Res 11:668–673PubMedCrossRef Willms JD, Tremblay MS, Katzmarzyk PT (2003) Geographic and demographic variation in the prevalence of overweight Canadian children. Obes Res 11:668–673PubMedCrossRef
13.
go back to reference Silveira D, Taddei JA, Schimith Escrivao MA et al (2006) Risk factors for overweight among Brazilian adolescents of low-income families: a case-control study. Public Health Nutr 9:421–428PubMedCrossRef Silveira D, Taddei JA, Schimith Escrivao MA et al (2006) Risk factors for overweight among Brazilian adolescents of low-income families: a case-control study. Public Health Nutr 9:421–428PubMedCrossRef
14.
go back to reference Wahba IM, Mak RH (2007) Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol, published online March 14, 2007: doi:10.2215/CJN.04071206 Wahba IM, Mak RH (2007) Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol, published online March 14, 2007: doi:10.2215/CJN.04071206
15.
go back to reference Veugelers PJ, Fitzgerald AL (2005) Prevalence of and risk factors for childhood overweight and obesity. CMAJ 173:607–613PubMed Veugelers PJ, Fitzgerald AL (2005) Prevalence of and risk factors for childhood overweight and obesity. CMAJ 173:607–613PubMed
17.
go back to reference Hedley AA, Ogden CL, Johnson CL et al (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291:2847–2850PubMedCrossRef Hedley AA, Ogden CL, Johnson CL et al (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291:2847–2850PubMedCrossRef
18.
go back to reference Janssen I, Katzmarzyk PT, Boyce WF et al (2004). Overweight and obesity in Canadian adolescents and their associations with dietary habits and physical activity patterns. J Adolesc Health 35:360–367PubMed Janssen I, Katzmarzyk PT, Boyce WF et al (2004). Overweight and obesity in Canadian adolescents and their associations with dietary habits and physical activity patterns. J Adolesc Health 35:360–367PubMed
19.
go back to reference Foster BJ, Shults J, Zemel BS et al (2004) Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr 80:1334–1341PubMed Foster BJ, Shults J, Zemel BS et al (2004) Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr 80:1334–1341PubMed
20.
go back to reference Robinson RF, Batisky DL, Hayes JR et al (2004) Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol 19:1379–1384PubMedCrossRef Robinson RF, Batisky DL, Hayes JR et al (2004) Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol 19:1379–1384PubMedCrossRef
21.
go back to reference Feld LG, Springate JE, Waz WR (1998) Special topics in pediatric hypertension. Semin Nephrol 18:295–303PubMed Feld LG, Springate JE, Waz WR (1998) Special topics in pediatric hypertension. Semin Nephrol 18:295–303PubMed
22.
go back to reference Horn NJ, Watson AR, Coleman JE (1994) Hypertensive adolescents detected by a school surveillance programme: a problem of obesity. J Hum Hypertens 8:319–321PubMed Horn NJ, Watson AR, Coleman JE (1994) Hypertensive adolescents detected by a school surveillance programme: a problem of obesity. J Hum Hypertens 8:319–321PubMed
23.
go back to reference Filler G, Young E, Geier P et al (2003) Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 42:1107–1113PubMedCrossRef Filler G, Young E, Geier P et al (2003) Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 42:1107–1113PubMedCrossRef
24.
go back to reference Luma GB, Spiotta RT (2006) Hypertension in children and adolescents. Am Fam Physician 73:1558–1568PubMed Luma GB, Spiotta RT (2006) Hypertension in children and adolescents. Am Fam Physician 73:1558–1568PubMed
25.
go back to reference Tuomilehto J, Lindstrom J, Eriksson JG et al, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG et al, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef
26.
go back to reference Barrett T, Ehtisham S, Maher E (2004) The changing face and implications of childhood obesity. N Engl J Med 350:2414–2416PubMedCrossRef Barrett T, Ehtisham S, Maher E (2004) The changing face and implications of childhood obesity. N Engl J Med 350:2414–2416PubMedCrossRef
Metadata
Title
Pediatric nephrology patients are overweight: 20 years' experience in a single Canadian tertiary pediatric nephrology clinic
Authors
Guido Filler
Sílvia Mansur Reimão
Anusha Kathiravelu
Joanne Grimmer
Janusz Feber
Alfred Drukker
Publication date
01-12-2007
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2007
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-007-9258-y

Other articles of this Issue 4/2007

International Urology and Nephrology 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine